Clinical research of intensive abdominal breathing in the treatment of patients with functional dyspepsia
Objective To explore the clinical effect of intensive abdominal breathing in the treatment of patients with functional dyspepsia(FD).Methods The patients with FD admitted to Taian Municipal Hospital from January 2022 to September 2023 were selected as study subject and divided into a control group and a research group according to the random number table method.The control group was treated with Moxabili combined with Rabeprazole,and the study group was treated with intensive abdominal breathing exercise.Both groups were treated for 8 weeks.The clinical effect,Gastrointestinal Symptom Rating Scale(GSRS)scores,World Health Organisation Quality of Life-100(WHOQOL-100)scores,Pittsburgh sleep quality index(PSQI)scores,Hospital Anxiety Depression Scale(HADS)scores and the incidence of adverse reactions of the two groups were compared.Results After treatment,the total effective rate of the research group was higher than that of the control group(P＜0.05).GSRS scores,PSQI scores and HADS scores in both groups were significantly decreased(P＜0.05),while WHOQOL-100 scores in both groups were significantly increased compared with before treatment(P＜0.05),and the scores of all scales in the research group improved significantly than those of the control group(P＜0.05).The incidence of adverse reactions in the research group was lower than that in the control group(P＜0.05).Conclusion Intensive abdominal breathing exercise can effectively improve the clinical symptoms,quality of life,sleep quality,anxiety and depression symptoms,and promote gastrointestinal motility of patients with FD,which is characterized by simplicity and proven efficacy.It can be used as an option in the treatment of FD.
Abdominal breathingFunctional dyspepsiaQuality of lifeClinical effect
万方数据
维普
